Hudson Bay Capital Management
HRMY icon

Hudson Bay Capital Management’s Harmony Biosciences HRMY Stock Holding History

Hudson Bay Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.04M Sell
138,500
-3,520
-2% -$111K 0.01% 560
2026
Q1 		$3.98M Buy
142,020
+3,520
+3% +$115K 0.01% 584
2025
Q4 		$5.18M Buy
+138,500
New +$4.55M 0.02% 492

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hudson Bay Capital Management's HRMY Position: Q2 2026 in Review

Hudson Bay Capital Management reduced its Harmony Biosciences (HRMY) stake by 2.5% in Q2 2026, selling an estimated $111K and leaving 138,500 shares worth $5.04M. The position accounts for 0.01% of the portfolio, ranked #560.

Hudson Bay Capital Management first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.18M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Hudson Bay Capital Management held 138,500 shares of Harmony Biosciences worth $5.04M as of Q2 2026.
  • Hudson Bay Capital Management sold 3,520 Harmony Biosciences shares in Q2 2026, an estimated $111K.
  • Harmony Biosciences made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #560 holding.
  • Hudson Bay Capital Management first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Hudson Bay Capital Management's Harmony Biosciences position peaked at $5.18M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.